TABLE 2.
Follow-Up Changes of Clinical Scales and Phosphorylated α-Synuclein Load in Curcumin-Supplemented and Untreated Parkinson Disease Patients
Supplemented | p-Value | Untreated | p-Value | |
---|---|---|---|---|
UPDRS off (score) | 5 ± 5 | 0.0016* | 11 ± 5 | 0.0001* |
H&Y (score) | 0.2 ± 0.4 | 0.0655 | 0.7 ± 0.4 | 0.0001* |
COMPASS-31 (score) | −0.5 ± 3 | 0.99 | 6 ± 4 | 0.11 |
NMSS (score) | −2 ± 0.6 | 0.49 | 8 ± 7 | 0.0001* |
Samples rate (%) | −9 ± 8 | 0.52 | 18 ± 15 | 0.1 |
Adnexa rate (%) | −5 ± 3 | 0.6 | 4 ± 8 | 0.93 |
L-dopa (mg/day) | 0 | – | 150 ± 120 | 0.59 |
p-Values refer to comparisons from baseline (Table 1) and follow-up measurements. Data are reported as mean±SE.
Significant differences.